Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
Jacopo Parizzi, Non-Malignant Haematology and Nephro-Rheumatology Unit Head at Roche, shared on LinkedIn:
”Looking toward 2027 with a clear vision and an unwavering commitment to patients!
The Roche Italy Non-Malignant Hematology team recently spent two intense and inspiring days together.
Our goal? To map out our strategy and design our commitment for 2027, ensuring we continue to pioneer solutions that truly matter.
Every discussion, brainstorm, and plan we created was driven by a single, powerful mission: to make a meaningful difference in the lives of patients living with Hemophilia A and Paroxysmal Nocturnal Hemoglobinuria (PNH).
By looking ahead and working together, we transform our dedication into concrete impact for the healthcare community and the people who inspire our work every day.
Proud of this passionate team and incredibly excited for the future we are building together!”
Stay updated with Hemostasis Today.
-
Aug 25, 2026, 14:43Bipasha Nandi Jui: The Surprising Role of Fat Inside Bone Marrow
-
Aug 25, 2026, 14:32Soumya Das: AIIMS Nagpur Celebrates World Apheresis Awareness Day 2026
-
Aug 25, 2026, 14:31Vidyashri Hattigoudar: Essentials and Management of Hemophilia A
-
Aug 25, 2026, 14:22Kavya Keerthana: ASH 2026 Guidelines for Immune Thrombocytopenia
-
Aug 25, 2026, 14:02Innocent Mupunga: Sri Lanka Strengthens Blood Screening Quality Through International Collaboration
-
Aug 25, 2026, 14:00Mohamed Tawengi: Balancing Bleeding and Coronary Thrombosis in STEMI With ITP
-
Aug 25, 2026, 13:55Rodrigo Assar: Modeling and Simulation to Improve Thrombosis and Hemostasis Care
-
Aug 25, 2026, 13:47Ruchi Punamia: Building Stronger Foundations in Immunohematology
-
Aug 25, 2026, 13:46Owen McCarty: How Infection Activates Coagulation Through Factor XII